Insider Trading & Ownership of Douglas A. Dachille

Location
Saddle River, NJ
Summary
The estimated net worth of Douglas A. Dachille is at least $1,222,158 dollars as of 21 May 2026. Douglas A. Dachille is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $873.2K. Douglas A. Dachille is the Director of Equitable Holdings, Inc. and owns shares of Equitable Holdings, Inc. (EQH) stock worth about $289.2K. Douglas A. Dachille is the Director of PNC FINANCIAL SERVICES GROUP, INC. and owns shares of PNC FINANCIAL SERVICES GROUP, INC. (PNC) stock worth about $59.8K.
Signature
Stella Lee as attorney-in-fact for Douglas Dachille
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Douglas A. Dachille and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Douglas A. Dachille has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,222,158.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: BridgeBio Pharma, Inc. ($873,182).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Douglas A. Dachille

Insider Transactions Reported by Douglas A. Dachille:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .